Squarepoint’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Sell |
42,070
-97,422
| -70% | -$2.8M | ﹤0.01% | 1422 |
|
|
2025
Q1 | $4.68M | Buy |
+139,492
| New | +$4.68M | 0.01% | 781 |
|
|
2024
Q4 | – | Sell |
-34,646
| Closed | -$1.77M | – | 2839 |
|
|
2024
Q3 | $1.77M | Buy |
34,646
+7,642
| +28% | +$391K | ﹤0.01% | 1174 |
|
|
2024
Q2 | $1.21M | Sell |
27,004
-7,179
| -21% | -$322K | ﹤0.01% | 1278 |
|
|
2024
Q1 | $1.6M | Sell |
34,183
-27,935
| -45% | -$1.31M | ﹤0.01% | 1136 |
|
|
2023
Q4 | $2.21M | Buy |
62,118
+31,226
| +101% | +$1.11M | ﹤0.01% | 981 |
|
|
2023
Q3 | $919K | Buy |
30,892
+781
| +3% | +$23.2K | ﹤0.01% | 1346 |
|
|
2023
Q2 | $543K | Buy |
+30,111
| New | +$543K | ﹤0.01% | 1561 |
|
|
2022
Q1 | – | Sell |
-12,554
| Closed | -$357K | – | 2331 |
|
|
2021
Q4 | $357K | Buy |
+12,554
| New | +$357K | ﹤0.01% | 1784 |
|
|
2021
Q1 | – | Sell |
-15,406
| Closed | -$217K | – | 2641 |
|
|
2020
Q4 | $217K | Buy |
+15,406
| New | +$217K | ﹤0.01% | 2079 |
|